Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
09/06/2025 13:43
June 9 (Reuters) - Elevation Oncology Inc ELEV.O: ELEVATION ONCOLOGY ENTERS INTO AGREEMENT TO BE ACQUIRED BY CONCENTRA BIOSCIENCES FOR $0.36 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHT ELEVATION ONCOLOGY INC - CONCENTRA TO BUY ELEVATION ONCOLOGY FOR $0.36 PER SHARE PLUS CVR ELEVATION ONCOLOGY INC - BOARD UNANIMOUSLY APPROVES MERGER AGREEMENT Source text: ID:nPn16tC9Xa Further company coverage: ELEV.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing